Clinical trial
Effect of Procrit (Epoetin Alfa) on Preventing Delayed Graft Function After…
NCT00425126 · West Penn Allegheny Health System, Other · Completed
Key facts
| NCT number | NCT00425126 |
|---|---|
| Title | Effect of Procrit (Epoetin Alfa) on Preventing Delayed Graft Function After Deceased Donor Renal Transplantation |
| Official title | Effect of Procrit(Epoetin Alfa) on Preventing Delayed Graft Function After Deceased Donor Renal Transplantation |
| Lead sponsor | West Penn Allegheny Health System, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Delayed Graft Function |
| Intervention type | Drug |
| Interventions | Epoetin Alfa |
| Enrollment | 76 |
| Start date | Feb 1, 2007 |
| Primary completion | Feb 1, 2010 |
| Completion | Feb 1, 2010 |
| First posted | Jan 22, 2007 |
| Last update posted | May 27, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: